MiniMed Group director files Form 3 insider report

MiniMed Group, Inc. filed an initial ownership report for director Walter Matthew R. This Form 3 filing for ticker MMED identifies him as a director of the company.

Accepted by SEC EDGAR 03/06/2026 - 06:15 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

MiniMed Group, Inc. filed an initial ownership report for director Walter Matthew R. This Form 3 filing for ticker MMED identifies him as a director of the company. The filing does not report any specific stock transactions or holdings, serving only as a baseline disclosure of insider status.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does MiniMed Group (MMED) disclose in this Form 3 filing?

MiniMed Group, Inc. discloses an initial ownership report on Form 3 for Walter Matthew R. The filing identifies him as a director but does not list any specific transactions or holdings, serving as a baseline insider disclosure for MMED.

Who is the reporting person in MiniMed Group (MMED)'s Form 3?

The reporting person is Walter Matthew R., who is identified as a director of MiniMed Group, Inc. The Form 3 establishes his status as an insider of MMED without detailing any buy, sell, or derivative transactions in this filing.

Does the MiniMed Group (MMED) Form 3 show any insider share purchases or sales?

No, the Form 3 for MiniMed Group, Inc. does not show any insider share purchases or sales. Transaction counts for buys, sells, exercises, gifts, and tax withholdings are all zero, indicating no reportable trading activity for Walter Matthew R. in this document.

What type of SEC filing is reported for MiniMed Group (MMED)?

The document is a Form 3, which is an initial statement of beneficial ownership. For MiniMed Group, Inc. (MMED), it records director Walter Matthew R. as an insider, but it does not include detailed holdings or any derivative positions in this particular filing.

Are any derivative securities reported for MiniMed Group (MMED) in this Form 3?

No derivative securities are reported for MiniMed Group, Inc. in this Form 3. The derivative summary is empty, and derivative transaction counts are zero, indicating no options, warrants, or similar instruments disclosed for director Walter Matthew R. in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Walter Matthew R.

(Last) (First) (Middle)

C/O 18000 DEVONSHIRE STREET

(Street)

NORTHRIDGE CA 91325

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
03/06/2026

3. Issuer Name and Ticker or Trading Symbol
MiniMed Group, Inc. [ MMED ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Bryan F. Kelly, attorney-in-fact	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.